Imaging Diagnostic Systems, Inc., (OTC Bulletin Board: IMDS), will be participating in the MEDICA 2006 exposition in Dusseldorf, Germany, November 15-18. IDSI will be located in the Florida Pavilion, Hall 16, stand C05.

MEDICA, the world's largest medical trade fair, attracts visitors from nearly 100 countries. Representing multiple areas of medicine, MEDICA features seminars, presentations, and courses along with the exhibition.

"As MEDICA is a business-to-business meeting, our primary objective there is to attract the interest of potential CTLM(R) distributors to expand our geographic commercial coverage," stated an IDSI spokesperson.

MEDICA 2005 attracted 137,122 attendees and more than 4,000 companies.

Imaging Diagnostic Systems is seeking FDA Premarket Approval (PMA) for its Computed Tomography Laser Mammography (CTLM(R)) system to be used as an adjunct to mammography. The FDA has determined that the Company's clinical investigation is a non-significant risk (NSR) investigational device study because it does not meet the definition of a significant risk (SR) device under 812.3(m) of the investigational device exemptions (IDE) regulation (21 CFR 812). The CTLMâ system is the first patented breast imaging system that utilizes state-of-the-art laser technology and patented algorithms to create 3-D images of the breast. It is a non-invasive, painless examination that does not expose the patient to radiation or require breast compression. The CTLM system is limited by United States Federal Law to investigational use only in the United States. Imaging Diagnostic Systems has received CE Marking, CMDCAS (Canada), Canadian License, China SFDA approval, UL listing, ISO 9001:2000, ISO 13485:2003 certification and FDA export certification for its CT Laser Mammography system.

As contemplated by the provisions of the Safe Harbor section of the Private Securities Litigation Reform Act of 1995, this news release may contain forward-looking statements pertaining to future, anticipated, or projected plans, performances and developments, as well as other statements relating to future operations. All such forward-looking statements are necessarily only estimates or predictions of future results or events and there can be no assurance that actual results or events will not materially differ from expectations. Further information on potential factors that could affect Imaging Diagnostic Systems, Inc., is included in the Company's filings with the Securities and Exchange Commission. We expressly disclaim any intent or obligation to update any forward-looking statements.

Imaging Diagnostic Systems, Inc.